切换至 "中华医学电子期刊资源库"

中华神经创伤外科电子杂志 ›› 2019, Vol. 05 ›› Issue (06) : 345 -348. doi: 10.3877/cma.j.issn.2095-9141.2019.06.006

所属专题: 文献

临床研究

慢性硬膜下血肿复发的影像学因素分析
张毅1, 严红燕1, 彭强2, 戴勇1, 王蕾2,()   
  1. 1. 226001 南通,南通大学第二附属医院神经外科
    2. 226001 南通,南通大学第二附属医院急诊中心
  • 收稿日期:2019-06-10 出版日期:2019-12-15
  • 通信作者: 王蕾
  • 基金资助:
    江苏省科技厅自然科学基金(BK20161290); 南通市科技计划项目(MS12015109); 南通市卫计委科研项目(WKZL2018024)

Analysis on imaging related factors of recurrence of chronic subdural hematoma

Yi Zhang1, Hongyan Yan1, Qiang Peng2, Yong Dai1, Lei Wang2,()   

  1. 1. Department of Neurosurgery, the Second Hospital Affiliated to Nantong University, Nantong 226001, China
    2. Department of Emergency Center, the Second Hospital Affiliated to Nantong University, Nantong 226001, China
  • Received:2019-06-10 Published:2019-12-15
  • Corresponding author: Lei Wang
  • About author:
    Corresponding author: Wang Lei, Email:
引用本文:

张毅, 严红燕, 彭强, 戴勇, 王蕾. 慢性硬膜下血肿复发的影像学因素分析[J/OL]. 中华神经创伤外科电子杂志, 2019, 05(06): 345-348.

Yi Zhang, Hongyan Yan, Qiang Peng, Yong Dai, Lei Wang. Analysis on imaging related factors of recurrence of chronic subdural hematoma[J/OL]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2019, 05(06): 345-348.

目的

通过影像学检查评估慢性硬膜下血肿(CSDH)复发的危险因素。

方法

收集2014年1月至2018年12月在南通大学第二附属医院神经外科接受CSDH手术治疗的113例患者的临床资料。所有患者均接受钻孔外引流手术治疗,术后随访时间超过3个月,比较复发组与未复发组患者的临床资料,采用多因素Logistic回归分析CSDH患者复发的危险因素。

结果

113例患者中,术后复发患者10例,未复发患者103例,术后复发率8.8%。复发组患者与非复发组患者在性别、年龄、术前血肿厚度、中线偏移比较差异均无统计学意义(P>0.05),复发组与未复发组患者的血肿类型、血肿侧别比较,差异均具有统计学意义(P<0.05)。将单因素分析中有统计学意义的变量纳入Logistic回归分析,结果显示术前分隔分层和双侧血肿是CSDH复发的独立危险因素。

结论

影像学术前血肿分隔分层型和双侧血肿是CSDH复发的危险因素。

Objective

To evaluate and predict the related factors of chronic subdural hematoma (CSDH) recurrence by imaging examination.

Methods

Clinical data of 113 patients who underwent surgical treatment of CSDH in neurosurgery at the Second Hospital Affiliated to Nantong University from January 2014 to December 2018 were collected. All patients underwent external drainage surgery. The follow-up time was more than 3 months. The clinical data of patients with relapse and non-recurrence were compared. Multivariate logistic regression was used to analyze the risk factors of recurrence in CSDH patients.

Results

Of the 113 patients, 10 had recurrence and 103 had no recurrence, and the recurrence rate was 8.8%. There were no significant differences in gender, age, preoperative hematoma thickness and midline deviation between the relapsed group and the non-recurrent group (P>0.05). The hematoma type and hematoma side of the relapsed group and the non-recurrent group were compared. The differences were statistically significant (P<0.05). Statistically significant variables in the univariate analysis were included in the logistic regression analysis. The results showed that preoperative stratification and bilateral hematoma were independent risk factors for CSDH recurrence.

Conclusion

The risk factors for the recurrence of CSDH are the types of hematoma separation and stratification and bilateral hematoma before imaging.

表1 复发组和非复发组的相关因素比较
表2 血肿术后复发因素Logistic回归分析
[1]
白金鑫,王跃彬,陈宁,等.慢性硬膜下血肿的治疗研究进展[J].临床医药实践, 2018, 27(3): 210-213.
[2]
胡杨杨,戴易.慢性硬膜下血肿治疗新策略[J].沈阳医学院学报, 2018, 20(2): 174-177.
[3]
Lee JM, Park JC, Kim JH. Retrospective analysis of risk factors for recurrent chronic subdural hematoma[J]. Nerve, 2016, 2(2): 54-58.
[4]
Jeong SI, Kim SO, Won YS, et al. Clinical analysis of risk factors for recurrence in patients with chronic subdural hematoma undergoing burr hole trephination[J]. Korean J Neurotrauma, 2014, 10(1): 15-21.
[5]
文传志.慢性硬膜下血肿术后复发因素分析[J].中国社区医师, 2019, 35(1): 73-74.
[6]
胡杨杨,狄广福,徐宗华,等.慢性硬膜下血肿术后复发危险因素分析及防治策略[J].皖南医学院学报, 2018, 37(2): 170-172.
[7]
Delgado Almandoz JE, Yoo AJ, Stone MJ, et al. The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors[J]. Stroke, 2010, 41(1): 54-60.
[8]
Li Q, Liu QJ, Yang WS, et al. Island sign: an imaging predictor for early hematoma expansion and poor outcome in patients with intracerebral hemorrhage[J]. Stroke, 2017, 48(11): 3019-3025.
[9]
Kuwabara M, Sadatomo T, Yuki K, et al. The effect of irrigation solutions on recurrence of chronic subdural hematoma: a consecutive cohort study of 234 patients[J]. Neurol Med Chir (Tokyo), 2017, 57(5): 210-216.
[10]
Kim J, Moon J, Kim T, et al. Risk factor analysis for the recurrence of chronic subdural hematoma: a review of 368 consecutive surgical cases[J]. Korean J Neurotrauma, 2015, 11(2): 63-69.
[11]
Hammer A, Tregubow A, Kerry G, et al. Predictors for recurrence of chronic subdural hematoma[J]. Turk Neurosurg, 2016, 27(5): 756-762.
[12]
Yan C, Yang MF, Huang YW. A reliable nomogram model to predict the recurrence of chronic subdural hematoma after burr hole surgery[J]. World Neurosurg, 2018, 118: e356-e366.
[13]
Yamamoto H, Hirashima Y, Hamada H, et al. Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model[J]. J Neurosurg, 2003, 98(6): 1217-1221.
[14]
Lee JM, Park JC, Kim JH. Retrospective analysis of risk factors for recurrent chronic subdural hematoma[J]. Nerve, 2016, 2(2): 54-58.
[15]
Jung YG, Jung NY, Kim E. Independent predictors for recurrence of chronic subdural hematoma[J]. J Korean Neurosurg Soc, 2015, 57(4): 266-270.
[16]
Hammer A, Tregubow A, Kerry G, et al. Predictors for recurrence of chronic subdural hematoma[J]. Turk Neurosurg, 2017, 27(5): 756-762.
[17]
Tokmak M, Iplikcioglu AC, Bek S, et al. The role of exudation in chronic subdural hematomas[J]. J Neurosurg, 2007, 107(2): 290-295.
[18]
Song DH, Kim YS, Chun HJ, et al. The predicting factors for recurrence of chronic subdural hematoma treated with burr hole and drainage[J]. Korean J Neurotrauma, 2014, 10(2): 41-48.
[1] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[2] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[3] 谢田伟, 庞于樊, 吴丽. 超声引导下不同消融术对甲状腺良性结节体积缩减率、复发率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 80-83.
[4] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[5] 曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[6] 高建新, 王啸飞, 于淼, 路夷平. 局部进展期直肠癌新辅助治疗后行ISR术远切缘距离的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 539-543.
[7] 丁志翔, 于鹏, 段绍斌. 血浆BRAF基因检测对腹腔镜右半结肠癌D3根治术中行幽门淋巴结清扫的指导价值[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 570-573.
[8] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[9] 皮尔地瓦斯·麦麦提玉素甫, 李慧灵, 艾克拜尔·艾力, 李赞林, 王志, 克力木·阿不都热依木. 生物补片修补巨大复发性腹壁切口疝临床疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 624-628.
[10] 周艳, 李盈, 周小兵, 程发辉, 何恒正. 不同类型补片联合Nissen 胃底折叠术修补食管裂孔疝的疗效及复发潜在危险因素[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 528-533.
[11] 闫亚飞, 范学圣, 张舰, 吴勇. 经腹腹膜前疝修补术治疗复发腹股沟疝的临床效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 552-556.
[12] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[13] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[14] 邓万玉, 陈富, 许磊波. 肝硬化与非肝硬化乙肝相关性肝癌患者术后无复发生存比较及其影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 670-674.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要